跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDE GRINDEKS HARD CAPSULE 15MG - HSA Drug Approval Details
Approvals
/
HSA
/
LENALIDOMIDE GRINDEKS HARD CAPSULE 15MG
Approved
THERAPEUTIC
LENALIDOMIDE GRINDEKS HARD CAPSULE 15MG
JOINT STOCK COMPANY GRINDEKS
🇸🇬 Health Sciences Authority
Approval Date
Jan 2, 2025
Approval ID
916a82a5f9d8598a
Company
JOINT STOCK COMPANY GRINDEKS
Type
Therapeutic
Approval Details
Approval Id
916a82a5f9d8598a
Drug Name
LENALIDOMIDE GRINDEKS HARD CAPSULE 15MG
Product Name
LENALIDOMIDE GRINDEKS HARD CAPSULE 15MG
Approval Number
SIN17158P
Approval Date
2025-01-02
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
L04AX04
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
Lenalidomide ammonium chloride equivalent to lenalidomide
15mg
Lenalidomide ammonium chloride equivalent to lenalidomide
15mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 2, 2025
Approval ID
916a82a5f9d8598a
Type
Therapeutic
Back to HSA Approvals